Movement Alert｜Liquidia Technologies Inc Rises 5.57% in Pre-Market Trading, Trading at $90.00

Market Focus

07/27

On July 27, Liquidia Technologies Inc rose 5.57% in pre-market trading, trading at $90.00 USD/share, with Turnover of $160,600.

Within the Pharmacy sector where Liquidia Technologies Inc belongs, the overall sector performance is relatively flat. Among individual stocks, Eli Lilly up 0.25%, Johnson & Johnson up 0%, Merck up 0.18%, Bristol-Myers Squibb up 0.34%, Pfizer up 0.16%.

Liquidia Corporation is a biopharmaceutical company that develops, manufactures, and commercializes products for unmet patient needs. Its lead product is YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. The company is headquartered in Morrisville, North Carolina.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1134201539"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1134201539\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1134201539?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-27 19:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1134201539","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Liquidia Technologies Inc Rises 5.57% in Pre-Market Trading, Trading at $90.00","media":"Market Focus","content":"<p><p>On July 27, Liquidia Technologies Inc rose 5.57% in pre-market trading, trading at $90.00 USD/share, with Turnover of $160,600.</p><p>Within the Pharmacy sector where Liquidia Technologies Inc belongs, the overall sector performance is relatively flat. Among individual stocks, Eli Lilly up 0.25%, Johnson & Johnson up 0%, Merck up 0.18%, Bristol-Myers Squibb up 0.34%, Pfizer up 0.16%.</p><p>Liquidia Corporation is a biopharmaceutical company that develops, manufactures, and commercializes products for unmet patient needs. Its lead product is YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. The company is headquartered in Morrisville, North Carolina.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Liquidia Technologies Inc Rises 5.57% in Pre-Market Trading, Trading at $90.00</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Liquidia Technologies Inc Rises 5.57% in Pre-Market Trading, Trading at $90.00\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-27 19:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 27, Liquidia Technologies Inc rose 5.57% in pre-market trading, trading at $90.00 USD/share, with Turnover of $160,600.</p><p>Within the Pharmacy sector where Liquidia Technologies Inc belongs, the overall sector performance is relatively flat. Among individual stocks, Eli Lilly up 0.25%, Johnson & Johnson up 0%, Merck up 0.18%, Bristol-Myers Squibb up 0.34%, Pfizer up 0.16%.</p><p>Liquidia Corporation is a biopharmaceutical company that develops, manufactures, and commercializes products for unmet patient needs. Its lead product is YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. The company is headquartered in Morrisville, North Carolina.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LQDA","symbol_name":"Liquidia Technologies Inc","start_time":0,"source_url":"","article_id":"1134201539","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1134201539","pubTimestamp":1785150141,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 27, Liquidia Technologies Inc rose 5.57% in pre-market trading, trading at $90.00 USD/share, with Turnover of $160,600.Within the Pharmacy sector where Liquidia Technologies Inc belongs, the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LQDA":"Liquidia Technologies Inc"},"translate_title":"走势警报|Liquidia Technologies Inc 在盘前交易中上涨 5.57%，交易价格为 90.00 美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LQDA":1},"content_text":"On July 27, Liquidia Technologies Inc rose 5.57% in pre-market trading, trading at $90.00 USD/share, with Turnover of $160,600.Within the Pharmacy sector where Liquidia Technologies Inc belongs, the overall sector performance is relatively flat. Among individual stocks, Eli Lilly up 0.25%, Johnson & Johnson up 0%, Merck up 0.18%, Bristol-Myers Squibb up 0.34%, Pfizer up 0.16%.Liquidia Corporation is a biopharmaceutical company that develops, manufactures, and commercializes products for unmet patient needs. Its lead product is YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. The company is headquartered in Morrisville, North Carolina.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}